University of Rhode Island
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rhode Island sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).
University of Rhode Island: 29 sponsored US clinical trials, 3 recruiting.
University of Rhode Island sponsors 29 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 25 completed. 1 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anemia, with 2 trials.
Top-decile sponsor footprint
University of Rhode Island ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
25 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
29 total, page 1 of 1
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
NCT07217795
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults
NCT06409975
Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
NCT05380765
Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study
NCT07592858
NAD+ Oral Supplement Pilot Intervention in Adult Females
NCT06579209
Toward a Generalizable Closed-loop Neurofeedback-based BCI for Attention Training
NCT05908253
EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease
NCT05640167
Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects
NCT07384247
Atlas of Retinal Imaging in Alzheimer's Study
NCT03862222
A Home-based Intervention to Improve the Diet Quality of Preschoolers
NCT03923491
Targeted Food Incentives to Improve Diet Quality and Health Among Adults
NCT03748056
Motivational Interviewing and Neuroimaging With Adolescents
NCT03367858
Effects of a Resistance Training Program in Older Women With Sarcopenia
NCT02628145
Contraceptive Awareness and Reproductive Education
NCT01627574
Delayed Cord Clamping and Infant Brain Study
NCT01620008
Alcohol Screening & Brief Lntervention in Juvenile Justice: Filling the Gap
NCT02106754
18 Month Follow Up of Preterm Infants Enrolled in the Cord Clamping Study
NCT01426698
Placental Transfusion in Term Infants: A Pilot Study
NCT01924572
Comparing Population Cessation Services
NCT01566994
Effects of LDX on Functioning of College Students With ADHD
NCT01342445
Online Tailored Interventions & Relational Agents for Exercise and Sun Protection
NCT01458002
Optimal TTM Tailoring for Population Cessation
NCT01544010
Milking the Umbilical Cord at Term Cesarean Birth
NCT01630993
Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants
NCT00818220
Tailored Interventions to Prevent Substance Abuse
NCT01482975
Motivation and Skills for Detained Teen Smokers
NCT01387516
Skills and Motivation at the Rhode Island Training School (Project SMART) - 1
NCT00227890
Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail
NCT00506753
Effects of Delayed Cord Clamping in Very Low Birth Weight Infants
NCT00840983
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the University of Rhode Island pipeline
3 recruiting of 29 indexed (10% open); 25 completed (86%).
Phase mix: 1 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Anemia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rhode Island: open-pipeline peers nationwide
Peers matched on 29 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of Rhode Island sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 29 trials (± recruiting share)
- BeOne Medicines · 29 trials · 79% recruiting
- BioCryst Pharmaceuticals · 29 trials · 7% recruiting
- California Pacific Medical Center Research Institute · 29 trials · 10% recruiting
- Center for International Blood and Marrow Transplant Research · 29 trials · 24% recruiting
Sponsors near 10% open enrollment (± trial volume)
- National Institute of Environmental Health Sciences (NIEHS) · 10% recruiting · 145 trials
- SWOG Cancer Research Network · 10% recruiting · 270 trials
- University of Mississippi Medical Center · 10% recruiting · 96 trials
- James J. Peters Veterans Affairs Medical Center · 10% recruiting · 39 trials
Related
What to do with this University of Rhode Island page
29 registered trials is a research-attention snapshot, not an endorsement of University of Rhode Island or any single study.
- 3 of University of Rhode Island's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anemia is the condition University of Rhode Island studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rhode Island pipeline card: 29 registered trials from official public datasets.Report a data error.